Summary
Gisli Jenkins is a respiratory physician and cell & molecular biologist studying how the lung responds to injury to understand what drives progressive pulmonary fibrosis rather healing, repair and regeneration. He is an NIHR Research Professor, he leads the Margaret Turner Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute and is an honorary consultant physician at the Royal Brompton Hospital, London.
Publications
Journals
Kawano-Dourado L, Kulkarni T, Ryerson CJ, et al. , 2024, Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases., Thorax
Barth S, Edwards C, Borton R, et al. , 2024, REMOTE-ILD study: Description of the protocol for a multicentre, 12-month randomised controlled trial to assess the clinical and cost-effectiveness of remote monitoring of spirometry and pulse oximetry in patients with interstitial lung disease., Bmj Open Respir Res, Vol:11
Francesco L, Stewart I, Fabbri L, et al. , 2024, Mycophenolate and Azathioprine efficacy in interstitial lung disease: a systematic review and meta-analysis, Bmj Open Respiratory Research, Vol:11, ISSN:2052-4439
Montesi SB, Gomez CR, Beers M, et al. , 2024, Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report., Am J Respir Crit Care Med, Vol:209, Pages:362-373
Pitre T, Kawano-Dourado L, Kachkovski GV, et al. , 2023, Systemic corticosteroids in fibrotic lung disease: a systematic review and meta-analysis., Bmj Open Respir Res, Vol:10